Medical Xpress - latest medical and health news stories
Drug combination may become new standard treatment for advanced kidney cancer
Sun, 17 Feb 2019 13:40:03 EST
A combination of two drugs—one of them an immunotherapy agent—could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.
